Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 9.840
- +2.480+33.70%
Close May 2 16:00 ET
- 9.898
- +0.058+0.58%
Post 16:23 ET
1.49BMarket Cap-10.36P/E (TTM)
10.280High8.570Low15.32MVolume8.810Open7.360Pre Close150.98MTurnover15.35%Turnover RatioLossP/E (Static)151.92MShares10.28052wk High7.85P/B982.14MFloat Cap2.99052wk Low--Dividend TTM99.81MShs Float71.250Historical High--Div YieldTTM23.23%Amplitude2.280Historical Low9.855Avg Price1Lot Size
About Adaptive Biotechnologies Company
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Company Profile
SymbolADPT
Company NameAdaptive Biotechnologies
Listing DateJun 27, 2019
Issue Price20.00
Founded2009
CEOMr. Chad M. Robins
MarketNASDAQ
Employees619
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067
Company Executives
- Name
- Position
- Salary
- Chad M. Robins
- Chairman of the Board and Chief Executive Officer
- 4.97M
- Susan Bobulsky
- Chief Commercial Officer, Minimal Residual Disease
- --
- Julie Rubinstein
- President and Chief Operating Officer
- 2.64M
- Kyle Piskel
- Chief Financial Officer and Principal Accounting Officer
- 1.29M
- Francis Lo
- Chief People Officer
- --
- Dr. Sharon Benzeno, PhD
- Chief Commercial Officer, Immune Medicine
- 1.80M
- Dr. Harlan Robins, PhD
- Chief Scientific Officer
- 4.54M
- Michelle Griffin
- Independent Director
- 330.00K
- Katey Einterz Owen
- Independent Director
- 310.00K
- Peter M. Neupert
- Lead Independent Director
- 355.00K
- Dr. Robert M. Hershberg, M.D.,PhD
- Independent Director
- 325.00K
- Dr. Michael J. Pellini,M.D.
- Independent Director
- 310.00K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
